Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0002036042-25-000047
Filing Date
2025-08-11
Accepted
2025-08-11 07:21:46
Documents
53
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q sionna-20250630.htm   iXBRL 10-Q 1401682
2 EX-31.1 exhibit311q22025.htm EX-31.1 12160
3 EX-31.2 exhibit312q22025.htm EX-31.2 12215
4 EX-32.1 exhibit321q22025.htm EX-32.1 11129
  Complete submission text file 0002036042-25-000047.txt   5307273

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sionna-20250630.xsd EX-101.SCH 25880
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT sionna-20250630_cal.xml EX-101.CAL 54352
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT sionna-20250630_def.xml EX-101.DEF 136026
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sionna-20250630_lab.xml EX-101.LAB 457030
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sionna-20250630_pre.xml EX-101.PRE 296767
56 EXTRACTED XBRL INSTANCE DOCUMENT sionna-20250630_htm.xml XML 581670
Mailing Address 21 HICKORY DRIVE, SUITE 500 WALTHAM MA 02451
Business Address 21 HICKORY DRIVE, SUITE 500 WALTHAM MA 02451 617-819-2020
Sionna Therapeutics, Inc. (Filer) CIK: 0002036042 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-42504 | Film No.: 251200165
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)